Discover 1,131 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
With many research studies being conducted across the state, Indiana provides opportunities for both healthy volunteers interested in paid studies and individuals with specific health needs. Research centers in Indianapolis, Fort Wayne, and South Bend are actively recruiting participants, granting access to advanced treatments and innovative healthcare.
Filter
1
Filter results
Results: 1,131
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Location: Boston MA, New York NY, Indianapolis IN, Aurora CO,
Sponsor: Oregon Health and Science University
Sex: All
Age: 18+
Code: NCT07282639
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
for
Atrial Fibrillation (AF)
Location: Moncton, Rimouski, Boston MA, Quebec, Sherbrooke,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07175428
Phase 2, Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
for
Uncontrolled Hypertension
Location: Boston MA, Methuen MA, Waterbury CT, The Bronx NY,
Sponsor: Retension Pharmaceuticals. Inc.
Sex: All
Age: 18 - 70+
Code: NCT07142356
Phase 2, Recruiting
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
for
B-cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Fairfax VA, Macon GA, Fort Wayne IN, Indianapolis IN,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07516093
Phase 3, Recruiting
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Cromwell CT, New York NY, Chapel Hill NC, Peterborough,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07783542
Phase 2, Recruiting
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Boston MA, Quebec, Montreal, Plymouth Meeting PA,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07733765
Phase 3, Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
for
Higher-risk Myelodysplastic Syndrome
Location: The Bronx NY, New York NY, Hackensack NJ, Montreal,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06641414
Phase 3, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Danvers MA, Newton MA, Boston MA, Providence RI,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
Virtue® SAB in the Treatment of Coronary ISR Trial
for
Coronary Artery Disease
Location: Springfield MA, Roslyn NY, New York NY, Philadelphia PA,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT07045194
Recruiting
Prebiotics (Dried Plum) and Immune Function in Postmenopausal Women
for
T Cell Response to Dried Plum,
Location: Indianapolis IN
Sponsor: Indiana University
Sex: Female
Age: 60 - 70+
Code: NCT07222111
Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Boston MA, New York NY, Philadelphia PA, Glen Burnie MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
Safety and Efficacy of Flaus Electric Flosser on Plaque and Gingivitis Compared to a Manual Toothbrush
for
Gingivitis, Gingival Bleeding, Dental Plaque
Location: Fort Wayne IN
Sponsor: Flaus, Inc
Sex: All
Age: 18 - 70
Code: NCT07779564
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
for
Primary Membranous Nephropathy
Location: New York NY, Miami FL, Winter Park FL, Orlando FL,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07204275
Phase 2, Phase 3, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,